Abstract
Spinocerebellar ataxia with axonal neuropathy (SCAN1) is an autosomal recessive disorder caused by a specific point mutation (c.1478A>G, p.H493R) in the tyrosyl-DNA phosphodiesterase (TDP1) gene. Functional and genetic studies suggest that this mutation, which disrupts the active site of the Tdp1 enzyme, causes disease by a combination of decreased catalytic activity and stabilization of the normally transient covalent Tdp1-DNA intermediate. This covalent reaction intermediate can form during the repair of stalled topoisomerase I-DNA adducts or oxidatively damaged bases at the 3′ end of the DNA at a strand break. However, our current understanding of the biology of Tdp1 function in humans is limited and does not allow us to fully elucidate the disease mec
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
de Boer J, Hoeijmakers JH. Nucleotide excision repair and human syndromes. Carcinogenesis 2000; 21:453–60.
O’Driscoll M, Jeggo PA. The role of double-strand break repair—insights from human genetics. Nat Rev Genet 2006; 7:45–54.
Friedberg EC, Walker GC, Siede W et al. Disease states associated with defective biological responses to DNA damage. DNA Repair and Mutagenesis. Washington: ASM Press, 2006;863–1080.
Subba Rao K. Mechanisms of disease: DNA repair defects and neurological disease. Nat Clin Pract Neurol 2007; 3:162–72.
Barzilai A. The contribution of the DNA damage response to neuronal viability. Antioxid Redox Signal 2007; 9:211–8.
Chen L, Lee HM, Greeley GH Jr et al. Accumulation of oxidatively generated DNA damage in the brain: a mechanism of neurotoxicity. Free Radic Biol Med 2007; 42:385–93.
Lombard DB, Chua KF, Mostoslavsky R et al. DNA repair, genome stability and aging. Cell 2005; 120:497–512.
Gorbunova V, Seluanov A, Mao Z et al. Changes in DNA repair during aging. Nucleic Acids Res 2007; 35:7466–74.
Imam SZ, Karahalil B, Hogue BA et al. Mitochondrial and nuclear DNA-repair capacity of various brain regions in mouse is altered in an age-dependent manner. Neurobiol Aging 2006; 27:1129–36.
Intano GW, Cho EJ, McMahan CA et al. Age-related base excision repair activity in mouse brain and liver nuclear extracts. J Gerontol A Biol Sci Med Sci 2003; 58:205–11.
Lu T, Pan Y, Kao SY et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004; 429:883–91.
Rutten BP, Schmitz C, Gerlach OH et al. The aging brain: accumulation of DNA damage or neuron loss? Neurobiol Aging 2007; 28:91–8.
Katyal S, McKinnon PJ. DNA strand breaks, neurodegeneration and aging in the brain. Mech Ageing Dev 2008; 129:483–91.
Takashima H, Boerkoel CF, John J et al. Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat Genet 2002; 32:267–72.
Interthal H, Pouliot JJ, Champoux JJ. The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily. Proc Natl Acad Sci USA 2001; 98:12009–14.
Interthal H, Chen HJ, Kehl-Fie TE et al. SCAN1 mutant Tdp1 accumulates the enzyme-DNA intermediate and causes camptothecin hypersensitivity. EMBO J 2005; 24:2224–33.
Hirano R, Interthal H, Huang C et al. Spinocerebellar ataxia with axonal neuropathy: consequence of a Tdp1 recessive neomorphic mutation? EMBO J 2007; 26:4732–43.
Pouliot JJ, Yao KC, Robertson CA et al. Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes. Science 1999; 286:552–5.
Bertoncini CR, Meneghini R. DNA strand breaks produced by oxidative stress in mammalian cells exhibit 3′-phosphoglycolate termini. Nucleic Acids Res 1995; 23:2995–3002.
Henner WD, Rodriguez LO, Hecht SM et al. Gamma ray induced deoxyribonucleic acid strand breaks. 3′ Glycolate termini. J Biol Chem 1983; 258:711–3.
Povirk LF. DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: bleomycin, neocarzinostatin and other enediynes. Mutat Res 1996; 355:71–89.
Inamdar KV, Pouliot JJ, Zhou T et al. Conversion of phosphoglycolate to phosphate termini on 3′ overhangs of DNA double strand breaks by the human tyrosyl-DNA phosphodiesterase hTdp1. J Biol Chem 2002; 277:27162–8.
Zhou T, Lee JW, Tatavarthi H et al. Deficiency in 3′-phosphoglycolate processing in human cells with a hereditary mutation in tyrosyl-DNA phosphodiesterase (TDP1). Nucleic Acids Res 2005; 33:289–97.
Champoux JJ. DNA topoisomerases: structure, function and mechanism. Annu Rev Biochem 2001; 70:369–413.
Pommier Y, Pourquier P, Fan Y et al. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim Biophys Acta 1998; 1400:83–105.
Stewart L, Redinbo MR, Qiu X et al. A model for the mechanism of human topoisomerase I. Science 1998; 279:1534–41.
Pommier Y, Redon C, Rao VA et al. Repair of and checkpoint response to topoisomerase I-mediated DNA damage. Mutat Res 2003; 532:173–203.
Pourquier P, Pommier Y. Topoisomerase I-mediated DNA damage. Adv Cancer Res 2001; 80:189–216.
Hsiang YH, Lihou MG, Liu LF. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res 1989; 49:5077–82.
Tsao YP, Russo A, Nyamuswa G et al. Interaction between replication forks and topoisomerase I-DNA cleavable complexes: studies in a cell-free SV40 DNA replication system. Cancer Res 1993; 53:5908–14.
Wu J, Liu LF. Processing of topoisomerase I cleavable complexes into DNA damage by transcription. Nucleic Acids Res 1997; 25:4181–6.
Debethune L, Kohlhagen G, Grandas A et al. Processing of nucleopeptides mimicking the topoisomerase I-DNA covalent complex by tyrosyl-DNA phosphodiesterase. Nucleic Acids Res 2002; 30:1198–204.
El-Khamisy SF, Saifi GM, Weinfeld M et al. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature 2005; 434:108–13.
Yang SW, Burgin AB Jr, Huizenga BN et al. A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc Natl Acad Sci USA 1996; 93:11534–9.
Interthal H, Chen HJ, Champoux JJ. Human Tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages. J Biol Chem 2005; 280:36518–28.
Ponting CP, Kerr ID. A novel family of phospholipase D homologues that includes phospholipid synthases and putative endonucleases: identification of duplicated repeats and potential active site residues. Protein Sci 1996; 5:914–22.
Stuckey JA, Dixon JE. Crystal structure of a phospholipase D family member. Nat Struct Biol 1999; 6:278–84.
Davies DR, Interthal H, Champoux JJ et al. The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1. Structure (Camb) 2002; 10:237–48.
Raymond AC, Rideout MC, Staker B et al. Analysis of human tyrosyl-DNA phosphodiesterase I catalytic residues. J Mol Biol 2004; 338:895–906.
Davies DR, Interthal H, Champoux JJ et al. Insights into substrate binding and catalytic mechanism of human tyrosyl-DNA phosphodiesterase (Tdp1) from vanadate and tungstate-inhibited structures. J Mol Biol 2002; 324:917–32.
Hawkins AJ, Subler MA, Akopiants K et al. In vitro complementation of Tdp1 deficiency indicates a stabilized enzyme-DNA adduct from tyrosyl but not glycolate lesions as a consequence of the SCAN1 mutation. DNA Repair (Amst) 2009; 8:654–63.
Katyal S, el-Khamisy SF, Russell HR et al. TDP1 facilitates chromosomal single-strand break repair in neurons and is neuroprotective in vivo. EMBO J 2007; 26:4720–31.
Deng C, Brown JA, You D et al. Multiple endonucleases function to repair covalent topoisomerase I complexes in Saccharomyces cerevisiae. Genetics 2005; 170:591–600.
Dunlop J, Morin X, Corominas M et al. glaikit is essential for the formation of epithelial polarity and neuronal development. Curr Biol 2004; 14:2039–45.
Liu C, Pouliot JJ, Nash HA. Repair of topoisomerase I covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase Tdp1. Proc Natl Acad Sci USA 2002; 99:14970–5.
Vance JR, Wilson TE. Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage. Proc Natl Acad Sci USA 2002; 99:13669–74.
El-Khamisy SF, Katyal S, Patel P et al. Synergistic decrease of DNA single-strand break repair rates in mouse neural cells lacking both Tdp1 and aprataxin. DNA Repair (Amst) 2009; 8:760–6.
Liu C, Zhou S, Begum S et al. Increased expression and activity of repair genes TDP1 and XPF in nonsmall cell lung cancer. Lung Cancer 2007; 55:303–11.
McKinnon PJ, Caldecott KW. DNA strand break repair and human genetic disease. Annu Rev Genomics Hum Genet 2007; 8:37–55.
Dexheimer TS, Antony S, Marchand C et al. Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy. Anticancer Agents Med Chem 2008; 8:381–9.
Turashvili G, Kalloger S, Gelmon K et al. Subcellular protein expression pattern of the DNA repair enzyme Tdp1 is prognostic in breast cancer 2009. In Press.
Davies DR, Interthal H, Champoux JJ et al. Crystal structure of a transition state mimic for Tdp1 assembled from vanadate, DNA and a topoisomerase I-derived peptide. Chem Biol 2003; 10:139–47.
Davies DR, Interthal H, Champoux JJ et al. Explorations of peptide and oligonucleotide binding sites of tyrosyl-DNA phosphodiesterase using vanadate complexes. J Med Chem 2004; 47:829–37.
Liao Z, Thibaut L, Jobson A et al. Inhibition of human tyrosyl-DNA phosphodiesterase by aminoglycoside antibiotics and ribosome inhibitors. Mol Pharmacol 2006; 70:366–72.
Antony S, Marchand C, Stephen AG et al. Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1. Nucleic Acids Res 2007; 35:4474–84.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Walton, C., Interthal, H., Hirano, R., Salih, M.A.M., Takashima, H., Boerkoel, C.F. (2010). Spinocerebellar Ataxia with Axonal Neuropathy. In: Ahmad, S.I. (eds) Diseases of DNA Repair. Advances in Experimental Medicine and Biology, vol 685. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6448-9_7
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6448-9_7
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6447-2
Online ISBN: 978-1-4419-6448-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)